ID

13992

Description

This is an open-label (all people know the identity of the intervention), multicenter study in genotype 1 chronic HCV infected liver transplant patients who will be treated for 12 weeks with telaprevir 750 mg every 8 hours given in combination with Peg-IFN-alfa-2a and ribavirin followed by 36 weeks of treatment with Peg-IFN-alfa-2a and ribavirin alone. The total treatment duration will be 48 weeks. Safety will be evaluated throughout the study and will include evaluations of adverse events, clinical laboratory tests, electrocardiogram, vital signs, and physical examination. NCT01571583

Mots-clés

Versions (1)
  1. 21/03/2016 21/03/2016 -
Détendeur de droits

CC BY-NC 3.0

Téléchargé le

21 mars 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

VX-950HPC3006 NCT01571583 Graft Donor Pharmacogenomic Informed Consent recording

Anglais

VX-950HPC3006 NCT01571583 Graft Donor Pharmacogenomic Informed Consent recording

1 Formulaires  
Graft Donor Pharmacogenomic Informed Consent recording
Description

Graft Donor Pharmacogenomic Informed Consent recording

Is appropriate consent from graft donor available for Pharmacogenomic sample collection?
Description

If yes, please answer the following two questions If no, please submit form and complete PharGen Graft form

Type de données

boolean

Alias
UMLS CUI [1,1]
C0013018
UMLS CUI [1,2]
C0021430
date graft donor signed informed consent
Description

date graft donor signed informed consent

Type de données

date

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0011008
UMLS CUI [1,3]
C0029206
is a conclusive IL28B test result available?
Description

(either from previous graft donor testing or from a new test result obtained from donor tissue or cells)

Type de données

integer

Alias
UMLS CUI [1]
C1174094
Retour au début de la page

Similar models

VX-950HPC3006 NCT01571583 Graft Donor Pharmacogenomic Informed Consent recording

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Graft Donor Pharmacogenomic Informed Consent recording
appropriate consent from graft donor
Item
Is appropriate consent from graft donor available for Pharmacogenomic sample collection?
boolean
C0013018 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
date graft donor signed informed consent
Item
date graft donor signed informed consent
date
C0021430 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C0029206 (UMLS CUI [1,3])
Item
is a conclusive IL28B test result available?
integer
C1174094 (UMLS CUI [1])
conclusive IL28B test result
Code List
is a conclusive IL28B test result available?
CL Item
yes, please submit form and complete PharGen Donor form (1)
CL Item
no, please submit form and complete PharGen Graft form (2)
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial